4D Molecular Therapeutics Inc (FDMT) valuation · rev $85.2M
4D Molecular Therapeutics Inc (FDMT) rev $85.2M.
| Metric | Value |
|---|---|
| Market cap | $518.1M |
| Revenue | $85.2M |
| P/S | 6.1 |
FDMT valuation FAQ
What is FDMT's market cap?
4D Molecular Therapeutics Inc (FDMT) market cap is $518.1M on the latest cached fundamentals snapshot.
What is FDMT's latest revenue?
Latest cached 4D Molecular Therapeutics Inc (FDMT) revenue was $85.2M. Statements: https://lician.com/financials/fdmt
What is FDMT's price-to-sales ratio?
4D Molecular Therapeutics Inc (FDMT) price-to-sales (P/S) is 6.1, cached market cap $518.1M divided by revenue $85.2M.
How many FDMT valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for 4D Molecular Therapeutics Inc (FDMT): Market cap, Revenue, and P/S.
Where is FDMT valuation listed?
Cached valuation multiples for 4D Molecular Therapeutics Inc (FDMT) are listed at https://lician.com/valuation/fdmt.
Not investment advice. Cached rows, not a live tape.